Compounds > isoproterenol

isoproterenol and solabegron

isoproterenol has been researched along with solabegron in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Adkison, KK; Brown, KK; Cariello, NF; Chao, EY; Cowan, C; Deaton, DN; Donaldson, KH; Faison, WL; Hart, R; Lancaster, ME; Lin, J; Milliken, TO; Paulik, MA; Shearer, BG; Sherman, BW; Sugg, EE; Uehling, DE1
Hamada, K; Hamashima, H; Hattori, K; Imamura, E; Imanishi, M; Ishikawa, H; Itou, S; Matsui, S; Matsumura, Y; Nakajima, Y; Nakano, K; Sakurai, M; Takamura, F; Tomishima, Y; Ueshima, K; Unami, N; Washizuka, K; Yamamoto, N; Yamamoto, T1
Demura, K; Inoue, A; Kobayashi, K; Nureki, I; Nureki, O; Shihoya, W; Tanaka, T1

Other Studies

3 other study(ies) available for isoproterenol and solabegron

ArticleYear
Biarylaniline phenethanolamines as potent and selective beta3 adrenergic receptor agonists.
    Journal of medicinal chemistry, 2006, May-04, Volume: 49, Issue:9

    Topics: Adrenergic beta-3 Receptor Agonists; Aniline Compounds; Animals; Blood Glucose; Cell Line; Cricetinae; Cyclic AMP; Dogs; Ethanolamine; Glycosylation; Hemoglobins; Humans; Male; Mice; Molecular Structure; Receptors, Adrenergic, beta-3; Structure-Activity Relationship

2006
Discovery of a novel series of biphenyl benzoic acid derivatives as potent and selective human beta3-adrenergic receptor agonists with good oral bioavailability. Part I.
    Journal of medicinal chemistry, 2008, Mar-27, Volume: 51, Issue:6

    Topics: Administration, Oral; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Anesthesia; Animals; Benzoates; Biological Availability; Biphenyl Compounds; Blood Pressure; Carbachol; Dogs; Drug Design; Drug Evaluation, Preclinical; Female; Humans; Injections, Intravenous; Models, Animal; Molecular Structure; Stereoisomerism; Structure-Activity Relationship; Time Factors

2008
Cryo-EM structures of the β
    Biochemical and biophysical research communications, 2022, 06-30, Volume: 611

    Topics: Adrenergic beta-3 Receptor Agonists; Aniline Compounds; Benzoates; Biphenyl Compounds; Cryoelectron Microscopy; Diabetes Mellitus, Type 2; Humans; Isoproterenol; Receptors, Adrenergic, beta-3

2022